BCM-95 Curcumin Equals Effectiveness of Antidepressant Drugs

January 16, 2012

In a recently published study, a highly absorbable form of curcumin called BCM-95, from EuroPharma, Green Bay, WI, was compared to fluoxetine (one brand name is Prozac) and imipramine (one brand name is Tofranil) in an animal scientific model of depression and was found to be as effective in alleviating depression as either prescription drug.

The study, “Evaluation of Antidepressant-Like Activity of Curcumin and its Combination with Fluoxetine and Imipramine: an Acute and Chronic Study,” published in Acta Poloniae Pharmaceutica, also found no significant adverse safety issues with BCM-95 curcumin use.

The study authors theorize that “antidepressant like activity could be due to an increase in serotonin, norepinephrine and dopamine levels in the brain.”

BCM-95 curcumin is an extract of the spice turmeric, but only 2-5% of turmeric is curcumin. BCM-95 curcumin has been shown in published human studies to have up to 10 times the absorption of standard curcumin.
  • In the Post-Election Lull, Cultivate Clinical Allies

    In the Post-Election Lull, Cultivate Clinical Allies

    Erik Goldman, Holistic Primary Care||December 5, 2016
    Regulatory actions taken over the last six months could have lasting impact on the future of integrative medicine.

  • Emerging Challenges in the Cosmetics Market

    Emerging Challenges in the Cosmetics Market

    Greg Doherty, Bolton & Company and Joseph P. Schilleci, Jr., Schilleci & Tortorici, P.C.||December 5, 2016
    As in the dietary supplement industry, companies need to understand regulatory and liability insurance requirements.

  • Herbal Hopes for Brain Health

    Herbal Hopes for Brain Health

    Dilip Ghosh, PhD, FACN, nutriConnect||December 5, 2016
    Complementary and alternative medicine has an extensive history of use for management of age-related health issues.